Building Your Care Team
At a Glance
For primary acquired pure red cell aplasia, care is often coordinated between a local hematologist and a specialized bone marrow failure center. Bring marrow slides, imaging, blood-count trends, and transfusion records so experts can confirm the diagnosis and plan treatment.
Because primary Pure Red Cell Aplasia (PRCA) is so rare—affecting roughly one in a million adults—it is considered a rare bone marrow failure syndrome [1][2]. Navigating this diagnosis often requires a team approach that balances local convenience with specialized expertise in immunology and bone marrow biology.
Why Seek Specialized Care?
In most local clinics, a hematologist may see only a few cases of PRCA in their entire career. A highly competent local hematologist can safely manage your care, but seeking a second opinion or shared-care arrangement with a specialized marrow-failure clinic is often valuable for several reasons:
- Precision in Diagnosis: PRCA can mimic other serious conditions like Myelodysplastic Syndrome (MDS) or rare T-cell leukemias [1][3]. Specialists often collaborate with dedicated hematopathologists who review bone marrow slides and utilize advanced tools, such as Next-Generation Sequencing (NGS) and T-cell receptor clonality testing, when indicated to ensure your diagnosis is precise [4][1].
- Access to Registries and Trials: Specialized centers may participate in observational registries (such as the EPIC-F registry in some regions), which track patient outcomes to improve standard care [1]. They may also offer access to clinical trials for new therapies [5].
- Refractory Case Management: If your first treatment (like Cyclosporine) fails, a specialist center has the experience to safely manage more intensive “salvage” therapies like Anti-thymocyte Globulin (ATG) or Sirolimus [6][7].
Preparing Your “Diagnostic Packet”
When you consult a specialist or a major academic center, they will want to review your original data rather than just reading a summary. You can help coordinate these “artifacts” by communicating clearly with your local office:
- Pathology Slides and Blocks: This is the most critical item. Ask the specialist’s office which reports and slides they need, and have your local pathology department securely transfer your “aspirate smears,” “core biopsy slides,” and “paraffin blocks” for an independent review [8][1].
- Imaging Records: Ensure the actual digital images (usually sent securely electronically or on a CD) of your Chest CT scan, which was used to rule out a thymoma, are transferred [9][10].
- Blood Work Trends: A simple list of your recent Complete Blood Counts (CBC) and Absolute Reticulocyte Counts is vital. Specialists look at the trends in your count decline to help gauge your disease [11][1].
- Transfusion History: Keep a log of exactly how many units of red blood cells you have received and on what dates. This helps the team calculate your cumulative exposure and plan for iron overload monitoring [6].
Vetting Your Care Team
When meeting a new hematologist, remember that you are actively building a team for a rare condition. A qualified doctor will welcome these questions:
- “How frequently do you manage adult acquired PRCA?”
- “Do you have an experienced hematopathologist review my slides?”
- “If my condition becomes refractory (doesn’t respond to first-line drugs), what is the center’s experience with second-line immunosuppression?”
- “Are you comfortable coordinating my care with a marrow-failure specialist remotely?”
By building a team that is familiar with your rare condition, you ensure that your treatment plan is based on the most current evidence and the deepest possible expertise [1][6].
Common questions in this guide
Why should I see a PRCA specialist or bone marrow failure clinic?
What should I bring to a PRCA specialist appointment?
How can pathology review help confirm a PRCA diagnosis?
Can my local hematologist work with a specialized PRCA center?
What happens if cyclosporine does not work for PRCA?
Why does my transfusion history matter in PRCA?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many patients with adult acquired PRCA have you treated in the last two years, and what were their outcomes?
- 2.Are you comfortable collaborating with a specialized bone marrow failure center for a shared-care approach?
- 3.Will an experienced hematopathologist independently review my bone marrow slides and flow cytometry data?
- 4.Have we evaluated for conditions like T-LGL leukemia and MDS, and what specific findings informed that decision?
- 5.If I don't respond to standard cyclosporine, does this clinic have experience with salvage therapies like Sirolimus or ATG?
- 6.How do you coordinate with the blood bank to manage my long-term transfusion needs and monitor for iron overload?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Clinical heterogeneity and outcome of acquired PRCA: a multicenter European study.
Versino F, Michel M, Vidler J, et al.
Blood advances 2026; (10(15)):5285-5292 doi:10.1182/bloodadvances.2025019525.
PMID: 42200581 - 2
Pure Red Cell Aplasia That Developed 13 Years After Thymoma Treatment: A Case Report and Literature Review.
Kono K, Nakashima K, Tsubata Y, et al.
Thoracic cancer 2025; (16(17)):e70157 doi:10.1111/1759-7714.70157.
PMID: 40879193 - 3
Phagocytosis of Lymphocytes and Erythrocytes by B-Cell Lymphoma in a Patient With a Clinical Suspicion of Pure Red Cell Aplasia.
Cao T, Li Y, Peng X
Clinical case reports 2026; (14(1)):e71750 doi:10.1002/ccr3.71750.
PMID: 41473878 - 4
Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia.
Kawakami T, Sekiguchi N, Kobayashi J, et al.
Blood advances 2018; (2(20)):2704-2712 doi:10.1182/bloodadvances.2018022723.
PMID: 30337298 - 5
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes.
Kadia TM, Huang M, Pemmaraju N, et al.
NEJM evidence 2024; (3(6)):EVIDoa2300362 doi:10.1056/EVIDoa2300362.
PMID: 38804782 - 6
[Pure red cell aplasia: Diagnosis, classification and treatment].
Lobbes H
La Revue de medecine interne 2023; (44(1)):19-26 doi:10.1016/j.revmed.2022.10.385.
PMID: 36336519 - 7
Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
Huang Y, Chen M, Yang C, et al.
Leukemia 2022; (36(5)):1351-1360 doi:10.1038/s41375-022-01532-1.
PMID: 35256763 - 8
[A man in his forties with anaemia requiring transfusion].
Sandnes M, Helgeland L, Johansen S, Reikvam H
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2023; (143(15)) doi:10.4045/tidsskr.23.0022.
PMID: 37874056 - 9
Pure Red Cell Aplasia Associated with Thymolipoma: Complete Anaemia Resolution following Thymectomy.
Ferreira D, Ponraj R, Yeung A, de Malmanche J
Case reports in hematology 2018; (2018()):8627145 doi:10.1155/2018/8627145.
PMID: 30402302 - 10
True thymic hyperplasia causing pure red cell aplasia: a case report.
Mohammad A, Dawson AG, Bajaj A, Rathinam S
Interactive cardiovascular and thoracic surgery 2022; (34(4)):697-699 doi:10.1093/icvts/ivab301.
PMID: 34791240 - 11
A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia.
Yang L, Niu H, Zhang T, et al.
Annals of hematology 2024; (103(6)):1877-1885 doi:10.1007/s00277-024-05636-9.
PMID: 38308019
This page is for informational purposes only and does not constitute medical advice. A hematologist or specialized bone marrow failure team should help interpret your PRCA records and choose care for your situation.
Get notified when new evidence is published on Primary acquired pure red cell aplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.